August 20, 2017 10:59 PM ET

Healthcare Equipment and Supplies

Company Overview of Obalon Therapeutics, Inc.

Executive Profile

Raymond V. Dittamore

AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships


Mr. Raymond V. Dittamore, also known as Ray, served as an Audit Partner of Ernst & Young, LLP until June 2001. Mr. Dittamore has over three decades of public accounting experience, primarily served companies in the life sciences industry. He has over 35 years of service with Ernst & Young, including 14 years as the Managing Partner of its San Diego office. He served as Collaborative Editor for annual biotechnology report of Ernst & Young. He founded BIOCOM/ San Diego. ...

Corporate Headquarters

5421 Avenida Encinas
Carlsbad, California 92008

United States

Phone: 760-795-6558
Fax: --

Board Members Memberships



BS 1966
San Diego State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$13,750
Total Calculated Compensation$117,612

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Seth H. Z. Fischer Chief Executive Officer and Director
Scott W. Schorer Chief Executive Officer and President
GI Dynamics, Inc.
Michael A. Narachi M.S., M.B.A.President, Chief Executive Officer & Director
Orexigen Therapeutics, Inc.
Dan W. Gladney Chairman, President & CEO
EnteroMedics Inc.
Todd Newton Chief Executive Officer & Director
Apollo Endosurgery, Inc.
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Obalon Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at